◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › COLL

Collegium Pharmaceutical, Inc. (COLL) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-07-15

Collegium Pharmaceutical, Inc. (COLL) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Stoughton, United States with about 423 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, COLL reported $781M in revenue and $63M in net income.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Interactive charts & full statements → Open the COLL valuation workbench →

COLL Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$781M$631M$567M$464M
Gross Profit$463M$377M$326M$210M
Operating Income (EBIT)$178M$167M$167M$33M
Net Income$63M$69M$48M($25M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COLL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$194M$205M$209M$188M$178M
Gross Profit$117M$128M$129M$108M$97M
Operating Income (EBIT)$31M$61M$62M$35M$21M
Net Income$14M$17M$32M$12M$2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COLL Free Cash Flow History

COLL Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$1.7B$1.7B$1.1B$1.2B
Total Liabilities$1.4B$1.4B$948M$979M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive COLL viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← COLDAll stocksCOLM →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.